Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Cinven’s portfolio company Partner in Pet Food in connection with its acquisition of the Doggy
Mandate

Vinge advises Cinven’s portfolio company Partner in Pet Food in connection with its acquisition of the Doggy

July 08, 2020 EU, Competition and Regulatory Employment and Benefits IT, Telecommunications and Outsourcing Banking and Finance M&A Corporate Commercial

Vinge advises Cinven’s portfolio company Partner in Pet Food, a leading European pet food manufacturer, in connection with its acquisition of the Doggy Group (“Doggy”).

Doggy is a leading Swedish pet food producer and distribution with well-known brands such as Doggy, Mjau and Bozita. The acquisition will complement Partner in Pet Food's product range, geographical markets and distribution channels.

The transaction is conditional upon customary approvals by competition authorities.

Vinge’s team mainly consisted of partner Christina Kokko and associates Carl Sander, Hannah Kajlinger and Jonathan Riddersholm (M&A), Christoffer Nordin and Ellinor Wargenbrant (Corporate Commercial), Olof Löfvenberg (Environment & Permits), Axel Jansson and Felix Möller (Banking & Finance), Lisa Ullman and Ebba Svenburg (Employment), Karl-Hugo Engdahl (IT), Xandra Ståhlberg and Lisa Malmborg (Antitrust) and VDR-assistant Carl Bruneheim.

 

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

 Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

 HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

 Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026